CN106616595A - Health-care food preparation having strong oxidation resistance and oxygen deficient resistance and application - Google Patents
Health-care food preparation having strong oxidation resistance and oxygen deficient resistance and application Download PDFInfo
- Publication number
- CN106616595A CN106616595A CN201611061763.2A CN201611061763A CN106616595A CN 106616595 A CN106616595 A CN 106616595A CN 201611061763 A CN201611061763 A CN 201611061763A CN 106616595 A CN106616595 A CN 106616595A
- Authority
- CN
- China
- Prior art keywords
- parts
- food preparation
- health
- anoxia
- oxidation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 45
- 235000013305 food Nutrition 0.000 title claims abstract description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title abstract description 9
- 239000001301 oxygen Substances 0.000 title abstract description 9
- 229910052760 oxygen Inorganic materials 0.000 title abstract description 9
- 230000003647 oxidation Effects 0.000 title abstract description 3
- 238000007254 oxidation reaction Methods 0.000 title abstract description 3
- 230000002950 deficient Effects 0.000 title abstract 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 41
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 40
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 23
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 23
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 23
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 20
- 229960003080 taurine Drugs 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 206010021143 Hypoxia Diseases 0.000 claims description 45
- 206010002660 Anoxia Diseases 0.000 claims description 38
- 241000976983 Anoxia Species 0.000 claims description 38
- 230000007953 anoxia Effects 0.000 claims description 38
- 230000003064 anti-oxidating effect Effects 0.000 claims description 31
- 241000168525 Haematococcus Species 0.000 claims description 22
- 241000219095 Vitis Species 0.000 claims description 22
- 240000007164 Salvia officinalis Species 0.000 claims description 21
- 235000013402 health food Nutrition 0.000 claims description 21
- 235000005412 red sage Nutrition 0.000 claims description 21
- 229940089161 ginsenoside Drugs 0.000 claims description 17
- 229930182494 ginsenoside Natural products 0.000 claims description 17
- 230000036541 health Effects 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- 241000208340 Araliaceae Species 0.000 abstract description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 7
- 235000008434 ginseng Nutrition 0.000 abstract description 7
- 230000007774 longterm Effects 0.000 abstract description 3
- 241000168517 Haematococcus lacustris Species 0.000 abstract 1
- 240000006365 Vitis vinifera Species 0.000 abstract 1
- 229930182490 saponin Natural products 0.000 abstract 1
- 150000007949 saponins Chemical class 0.000 abstract 1
- 235000017709 saponins Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 16
- 210000004556 brain Anatomy 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 230000003078 antioxidant effect Effects 0.000 description 11
- 239000002775 capsule Substances 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 239000003963 antioxidant agent Substances 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 230000006378 damage Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000036542 oxidative stress Effects 0.000 description 6
- 201000006474 Brain Ischemia Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000003285 pharmacodynamic effect Effects 0.000 description 5
- 206010008120 Cerebral ischaemia Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical group SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 4
- 206010008118 cerebral infarction Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000001146 hypoxic effect Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 244000132619 red sage Species 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000009561 tongxinluo Substances 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061216 Infarction Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000004413 cardiac myocyte Anatomy 0.000 description 2
- 239000000496 cardiotonic agent Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000009189 diving Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 108010062745 Chloride Channels Proteins 0.000 description 1
- 102000011045 Chloride Channels Human genes 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 230000010558 Gene Alterations Effects 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002253 anti-ischaemic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- -1 carbohydrate peroxide Chemical class 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000002586 coronary angiography Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000012241 membrane hyperpolarization Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to a health-care food preparation having strong oxidation resistance and oxygen deficient resistance and an application. The health-care food preparation is prepared from the following raw materials in parts by weight: 0.1-10 parts of ginseng total saponins, 20-1500 parts of radix salviae miltiorrhizae, 20-1500 parts of grape seeds, 10-800 parts of haematococcus pluvialis, 10-200 parts of taurine, and 10-80 parts of gamma-aminobutyric acid. The health-care food preparation has the characteristics of being easy to absorb, safe and efficient, and can be taken for a long term.
Description
Technical field
The invention belongs to technical field of health care food, and in particular to a kind of health food preparation of strong anti-oxidation anti anoxia and
Using.
Background technology
Oxygen is material necessary to body tissue cell metabolism.Normal tissue cell oxygen supply relates generally to 5 links：
Air partial pressure of oxygen, pulmonary ventilation, pulmonary ventilation, gas transport and organization aeration.There is obstacle in one link of any of which, all can cause
Histocyte anoxic.Burden that social fast pace bears by brain and oxygen demand are plateau, aviation, diving, high-strength being continuously increased
Degree training and disease, inferior health can all cause body anoxic.
Another metabolism of human cell can be constantly be generated free radical, mainly peroxidating material, and with increasing, age body is clear
Except the ability of free radical (peroxidating material) declines, free radical is the unpaired electron of molecule, atom, ion and group outer layer,
There is very strong energy, can grab, capture an electronics and oneself pairing of normal bio molecule, destruction biological cell membrane, lyase
Body, mitochondria, DNA, RNA and protein structure etc., disturb the normal function of biological cell, make lipid, the carbohydrate peroxide of cell
Change, protein denaturation, enzyme body inactivation, immunocompromised host, gene alteration, cause canceration, fibrillatable, atherosclerotic, arthritis,
Many pathologies such as dull-witted, aging in advance, are the common roots of all chronic diseases and aging in advance.
Socially, one is numerous disease late period hypoxic-ischemic to occur, not only needs anti anoxia to treat, in addition it is also necessary to prevent and treat
Hypoxic oxidativestress damage；Two is that normal person enters plateau, high-altitude, deep-sea, mental labour excessively or inferior health all can occur
Anoxic, treatment not only needs anti anoxia, it is also desirable to prevent and treat Hypoxic oxidativestress damage；Three is that the elderly is not only needed by anti-
Oxidation carrys out anti-aging, while being also required to anti anoxia, the health status of maintenance organization cell strengthens the life of body tissue cell
Vigor.
Current present situation：Commercially health-care preparation is mostly the product of simple function, and identical product has anti-oxidant, anti-
Very less or nothing, this not only increases trouble when patient takes to the natural health-care products preparation of anoxic function, increases the heart also can to patient
Reason burden.So, researching and developing strong anti-oxidation anti-hypoxia preparations can cater to the needs of aforementioned Three Groups of Population, have very big market to need
Ask, for the anti anoxia, the oxidation resistance that lift body, safeguard that health has very important meaning.
The content of the invention
It is an object of the invention to overcome defect of the prior art, and one kind is provided and is easy to absorb, it is safe and efficient, can grow
A kind of health food preparation of strong anti-oxidation anti anoxia that the phase takes and application.
The object of the present invention is achieved like this：It is formulated according to parts by weight including following raw materials according：General ginsenoside
0.1～10 part, 20～1500 parts of the red sage root, 20～1500 parts of grape pip, 10～800 parts of haematococcus, 10～200 parts of taurine, γ
10～80 parts of aminobutyric acid.
A kind of health food preparation of strong anti-oxidation anti anoxia, 5 parts of general ginsenoside, 1000 parts of the red sage root, grape pip 860
Part, 26 parts of haematococcus, 80 parts of taurine, 72 parts of gamma aminobutyric acid.
A kind of health food preparation of strong anti-oxidation anti anoxia, including following raw materials according is formulated according to parts by weight：People
1.8 parts of total saposins of ginseng, 1200 parts of the red sage root, 60 parts of grape pip, 780 parts of haematococcus, 160 parts of taurine, 20 parts of gamma aminobutyric acid.
A kind of health food preparation of strong anti-oxidation anti anoxia, including following raw materials according is formulated according to parts by weight：People
0.2 part of total saposins of ginseng, 600 parts of the red sage root, 1280 parts of grape pip, 505 parts of haematococcus, 50 parts of taurine, 46 parts of gamma aminobutyric acid.
Present invention also offers a kind of above-mentioned health food preparation answering in strong anti-oxidation anti anoxia health food is prepared
With.
The present invention can make different formulations, such as capsule preparations, particle according to the different market demand and preparation technology
Agent, oral liquid, pressed candy etc..200～500mg of its capsule preparations per, pressed candy are per 300～6000mg of piece, granule
Often wrap 3～50g.
The present invention selects the pharmacology foundation of composition：
(1) anti anoxia composition：For general ginsenoside, the red sage root, anti-heart and brain anoxic can be cooperateed with, acute heart and brain anoxic is had significantly
Protective effect, can treat that angina pectoris, palpitaition are weak, brain is confused, brain is swollen.
(2) antioxidant content：For haematococcus, grape pip, oxidative stress can be suppressed, prevent the body that oxidative stress shines
The damage of cell；
(3) nourishing heart cardiac stimulant composition：For general ginsenoside and taurine, energy cardiac nutrition, strengthen heart function, accelerate blood to follow
Ring, improves the oxygen delivery capacity of body, and treatment palpitaition is weak；
(4) shield of calming the nerves brain composition：For gamma aminobutyric acid, energy keeping tensions down, brain oxygen consumption is reduced, increase blood supply in brain and supply
Oxygen amount, treatment is dizzy, dizzy, memory disorders；
(5) 6 kinds of composition Synergistics, strong anti anoxia is anti-oxidant, is remarkably improved patient and lacks with the anti-oxidant anti-of normal person
Oxygen ability.
The effect that 6 kinds of compositions of the invention are played according to monarch：
1st, general ginsenoside：General ginsenoside is monarch drug in a prescription, and it is ginseng extract.Can be qi-blood tonifying, reinforce the spleen to benefit the lung, calm the nerves
Intelligence development.【Pharmacological action】1. ginseng can adjust central nervous system stimulant and process of inhibition, there is tranquilizing and allaying excitement, make nervous disorder
Nervous activity is recovered.2. conditioning blood lipid, adjusts blood sugar, anti-oxidant, protects brain and cardiac muscle, increases cortex hormone of aadrenaline point
Secrete.3. suppress platelet aggregation, stimulate hematopoiesis function, stabilizing cell membrane, increase protein synthesis, strengthen memory etc..
2nd, the red sage root：The red sage root is ministerial drug, its bitter micro-pungent, cold nature；The thoughts of returning home, Liver Channel.【Indication】Promoting blood circulation, stimulates the menstrual flow
Pain relieving, relieving restlessness that clears away heart-fire.【Pharmacological action】1. circulatory system energy coronary artery dilator, improves core ischemia, infarct and heart function, protection
Cardiac muscle cell, improves microcirculation；There is anti-freezing, promote fibrinolytic, suppress platelet aggregation, inhibition thrombosis；Reducing blood lipid；Raising machine
The hypoxia-bearing capability of body.2. there is the relatively mild estrogen active worked by ovary.3. nervous centralis, enhancing is suppressed to exempt from
Epidemic disease, it is hypoglycemic to wait effect.
3rd, haematococcus：Haematococcus are ministerial drug, its quilt【Defend the new examination word (2007) the 0011st of food】It is classified as new food resource.
【Pharmacological action】1. haematococcus astaxanthin-containing, astaxanthin is the most strong antioxidant of nature, there is superpower non-oxidizability, is dimension
550 times of raw element E, can block lipid peroxidation, raise the function of HDL and drop LDL, prevent and treat the ischemic caused by artery sclerosis
The heart, brain equivalent damage.2. brain and eyes can be protected by blood-brain barrier.3. strengthen immunity, improve metabolism, fatigue-relieving etc..
4th, adjutant grape pip：Grape pip is adjutant, and grape pip is containing abundant anthocyanidin and resveratrol.【Pharmacological action】①
Cardiac stimulant, expansion of blood vessels adjusts blood fat, and drop blood glues, and anti-ischemic heart disease can softening blood vessel containing phytoestrogen.2. it is anti-oxidant
Activity is 50 times, ascorbic 20 times of dimension element E, can anti-aging, enhancing immunity.3. suppress platelet aggregation, promote fiber
Protein dissolution, antithrombus formation protects vascular endothelial cell, suppresses smooth muscle cell propagation, passes through blood-brain barrier protection nerve
Unit, improves the health care of sleep.
5th, adjutant taurine：Taurine is adjutant, and it is human amino acid, there is extensive physiology and pharmacologically active：1. it is
CNS inhibition mediator, energy nutrition brain has regulation body temperature, the effect such as antipyretic, calm, analgesia, anticonvulsion, suppression cataract；
2. can cardiac nutrition, strengthen myocardial contractive power, anti-arrhythmia；3. promote digesting and assimilating for lipid material, reduce cholesterolemia,
The effects such as hepatic cholagogic, removing toxic substances, enhancing immunity, anti-inflammatory, antirheumatic.
6th, medicine gamma aminobutyric acid (GABA) is made：Gamma aminobutyric acid, to make medicine, is 1. a kind of amino of natural non-protein composition
Acid, the important inhibitory neurotransmitter of human body opens can chloride channel, cause cell membrane hyperpolarization, have tranquilizing soporific, resist
Convulsions, hypotensive activity.2. there is brain tonic and intelligence development, beauty moisturizing suppresses fat, delays brain aging to act on.
The scope of application of strong anti-oxidation anti anoxia natural medicine of the present invention：One be acute and chronic body anoxic caused by disease with
Oxidativestress damage；Two is the working environment such as high intensity mental labour or plateau, high-altitude, diving anoxic and Hypoxic oxidative stress
Damage；Three is the mid-aged population of health anti-aging.
The present invention easily absorbs with pure natural, and high effect is nontoxic, is capable of the advantage of long-term taking.
Specific embodiment
The present invention is a kind of health food preparation of strong anti-oxidation anti anoxia, including following raw materials according is according to parts by weight preparation
Form：0.1～10 part of general ginsenoside, 20～1500 parts of the red sage root, 20～1500 parts of grape pip, 10～800 parts of haematococcus, ox sulphur
Sour 10～200 parts, 10～80 parts of gamma aminobutyric acid.
A kind of health food preparation of strong anti-oxidation anti anoxia, including following raw materials according is formulated according to parts by weight：People
5 parts of total saposins of ginseng, 1000 parts of the red sage root, 860 parts of grape pip, 26 parts of haematococcus, 80 parts of taurine, 72 parts of gamma aminobutyric acid.
A kind of health food preparation of strong anti-oxidation anti anoxia, including following raw materials according is formulated according to parts by weight：People
1.8 parts of total saposins of ginseng, 1200 parts of the red sage root, 60 parts of grape pip, 780 parts of haematococcus, 160 parts of taurine, 20 parts of gamma aminobutyric acid.
A kind of health food preparation of strong anti-oxidation anti anoxia, including following raw materials according is formulated according to parts by weight：People
0.2 part of total saposins of ginseng, 600 parts of the red sage root, 1280 parts of grape pip, 505 parts of haematococcus, 50 parts of taurine, 46 parts of gamma aminobutyric acid.
Present invention also offers a kind of above-mentioned health food preparation answering in strong anti-oxidation anti anoxia health food is prepared
With.
For the more detailed explanation present invention, the present invention is further elaborated in conjunction with embodiment.Specific embodiment
It is as follows：
Embodiment one
A kind of strong anti-oxidation anti anoxia natural health care preparation, including following raw materials according is formulated according to parts by weight：
0.2 part of general ginsenoside, 200 parts of the red sage root, 200 parts of grape pip, 100 parts of haematococcus, 10 parts of taurine, 10 parts of gamma aminobutyric acid.
Embodiment two
A kind of strong anti-oxidation anti anoxia natural health care preparation, including following raw materials according is formulated according to parts by weight：
5 parts of general ginsenoside, 1420 parts of the red sage root, 1200 parts of grape pip, 800 parts of haematococcus, 100 parts of taurine, 50 parts of gamma aminobutyric acid.
Embodiment three
A kind of strong anti-oxidation anti anoxia natural health care preparation, including following raw materials according is formulated according to parts by weight：
2.5 parts of general ginsenoside, 100 parts of the red sage root, 100 parts of grape pip, 500 parts of haematococcus, 100 parts of taurine, 55 parts of gamma aminobutyric acid.
Example IV
A kind of strong anti-oxidation anti anoxia natural health care preparation, including following raw materials according is formulated according to parts by weight：
0.5 part of general ginsenoside, 1200 parts of the red sage root, 1000 parts of grape pip, 600 parts of haematococcus, 100 parts of taurine, gamma aminobutyric acid 30
Part.
Embodiment five
A kind of strong anti-oxidation anti anoxia natural health care preparation, including following raw materials according is formulated according to parts by weight：
8 parts of general ginsenoside, 50 parts of the red sage root, 21 parts of grape pip, 1360 parts of haematococcus, 140 parts of taurine, 20 parts of gamma aminobutyric acid.
Embodiment six
A kind of strong anti-oxidation anti anoxia natural health care preparation, including following raw materials according is formulated according to parts by weight：
3 parts of general ginsenoside, 50 parts of the red sage root, 400 parts of grape pip, 625 parts of haematococcus, 36 parts of taurine, 10.6 parts of gamma aminobutyric acid.
Experimental example
1st, rat myocardial cell, brain cell anti anoxia pharmacodynamic experiment
Note：(1) * compares with model group, p ＜ 0.05.
(2) 1 group is tested：For entitled " composition and its application that a kind of strong anti-oxidation prevention of arterial is atherosis "
Patent, Application No.：" 201610584155.3 ", the applying date is：On July 14th, 2016.
(3) 2 groups are tested：For " a kind of composition of antiatherosclerosis cardiac-cerebral ischemia and application ", prepare to declare invention
Patent.
Can be seen that from cardiac muscle cell's anti anoxia pharmacodynamics experimental result：Present invention group anti anoxia drug effect ＞ tests 2 groups of ＞
Captopril group ＞ tests 1 group of ＞ HMP group.
Can be seen that from brain cell anti anoxia pharmacodynamics experimental result：Present invention group anti anoxia drug effect ＞ tests 2 groups, Kato
Puli group ＞ tests 1 group of ＞ HMP group
2nd, the anti-oxidant pharmacodynamic experiment of Human embryo huve cell
| Packet | n | SOD(U/ml) | MDA(pmol/ml) |
| Normal group | 8 | 21.63±5.72* | 141.53±11.67* |
| Hydrogen peroxide (H2O2) damage group | 8 | 4.14±0.76 | 292.25±22.16 |
| Tongxinluo medicinal capsule group | 8 | 10.31±3.53* | 215.38±24.51* |
| HMP group | 8 | 9.79±2.22* | 223.47±21.81* |
| Danshen Root dropping ball group | 8 | 7.93±3.05* | 203.51±14.51* |
| Captopril group | 8 | 15.37±3.41* | 179.71±12.46* |
| Test 1 group | 8 | 14.73±1.95* | 188.25±15.63* |
| Test 2 groups | 8 | 15.12±0.91* | 181.73±13.44* |
| Of the present invention group | 8 | 16.64±1.43* | 172.23±14.62* |
Note：(1) hydrogen peroxide (H2O2) it is peroxidating water, it is strong oxidizer, to the toxic damaging action of cell.
(2) * compares with model group, p ＜ 0.05.
(3) 1 group is tested：For entitled " composition and its application that a kind of strong anti-oxidation prevention of arterial is atherosis "
Patent, Application No.：" 201610584155.3 ", the applying date is：On July 14th, 2016.
(4) 2 groups are tested：For " a kind of composition of antiatherosclerosis cardiac-cerebral ischemia and application ", it is ready for declaring and sends out
Bright patent.
Can be seen that from the anti-oxidant pharmacodynamics experimental result of endothelial cell：Present invention group antioxidation is most strong, can be substantially
Increased SOD, effect ＞ Captopril groups ＞ anti-oxidant group of ＞ Tongxinluo medicinal capsule group of the anti-AS cardiac-cerebral ischemias group ＞ five tastes of increased SOD
＞ HMP group ＞ Danshen Root dropping ball groups；And MDA is significantly reduced, reduce the anti-AS heart and brain of effect ＞ Captopril groups ＞ of MDA
Anti-oxidant group of ＞ Danshen Root dropping ball group ＞ Tongxinluo medicinal capsule group ＞ HMP group of the ischemia group ＞ five tastes.
3rd, normal person's high altitude anoxia, takes and can significantly improve after the present invention symptom.
4th, it is front before the examination and in the test period, take and can be improved the health care of sleep after the present invention, keep human thinking clear.
5th, the atherosclerotic acute heart, cerebral anoxia, take and can improve quickly after the present invention hypoxic conditions, the stable state of an illness.
6th, the elderly, takes and can be obviously improved after the present invention health status and the state of mind, enhance immunity and life
Vigor, flu is significantly reduced, and the flu duration is greatly shortened.
The health food preparation that the present invention is constituted for a kind of strong anti-oxidation anti anoxia pure natural substance, its all constituent
It is the healthy food material of national regulation, pure natural, high effect strong anti-oxidation anti anoxia health food preparation.
Contained extract can use the crude drug containing equivalent functional component to substitute in 6 kinds of compositions of the invention；The present invention 6 kinds into
Contained crude drug can use the extract containing equivalent functional component to substitute in point.
Its formulation of the invention can be processed into different formulations according to the market demand and manufacture craft, it is possible to according to formulation
Needs addition meet the corresponding auxiliary material of national regulation.
Case 1：Lee, man, 57 years old, coronary heart disease of hypertension 7 years, diabetes 3 years, in June, the 2016 burst heart twisted pain, takes
Capsule preparations prepared by the present invention are eased, and persistently take two weeks, change and take antiatherosclerosis cardiac-cerebral ischemia preparation, adhere to
Non- hospitalization so far is taken, work of still going to work.
Case 2：Lou so-and-so, man, 49 years old, in September, 2016 was gone on business to Tibet, happen suddenly uncomfortable in chest, shortness of breath, giddy, weak, lip
Cyanosis, takes capsule preparations prepared by the standby present invention, and remission subsequently is adhered to taking for 5 days in Tibet, air hunger does not occur
Shape.
Case 3：Male in so-and-so, 82 years old, the one week interior frequently angina pectoris attacks of August in 2016, electrocardiogram was checked several times, ST
Section all shows obvious ischemic and changes, and has no infarct Q ripple, and the left Circumflex branch proximal segment narrow 80～90% of coronary angiography, all suggestion are put
Stent in the treatment, patient adheres to expectant treatment, voluntarily adheres to taking the capsule preparations of present invention preparation, and clothes " anti-artery congee is changed after January
Sample hardens cardiac-cerebral ischemia preparation ", show effect without chest pain so far, daily routines can be carried out, the state of mind is good.
Case 4：Guo, female, 17 years old, in May, 2016 met college entrance examination, giddy, headache, apocleisis, insomnia occurred, and the head of a family is very
Worry, start to take capsule preparations of the present invention, symptom is opened improvement and disappeared, still adheres to taking until college entrance examination terminates very much.Etc. take weight
Point college admission notice, it is very excited, represent the thanks of heart.
Case 5：It is remaining so-and-so, female, 53 years old, annual season must catch a cold, and continue 30～40 day time, and this year, September part was opened
Begin clothes capsule preparations of the present invention, and maintenance dose (daily 2～4) is slept, and energetically, October suffers from slight cold to whole body, does not take and controls
Cold drug, couple of days is all right, and the Ms proposes the present invention, and she wants long-term taking.
Case 6：It is high so-and-so, man, 85 years old, past body was healthy always, and late August engenders drowsiness, receives difference, weak,
Motionless, acral ice-cold, forgetful, One's spirits are drooping depressed grade senile symptom uses Chinese and Western medicine effect on driving birds is not good, household to feel very not
It is good.The present invention is learnt after three weeks, starts to try out capsule preparations of the present invention, three times a day, 3 every time, the state of mind is just shown in after two days
Improve, be clearly better within one week, present patient can take care of oneself life, stroll activity freely, is ready exchange, and household is very delight, meets
Just overstate the medicine effectively, it is very good.
Above-described embodiment is only intended to clearly illustrate example, and not to the restriction of embodiment.For institute
For the general technical staff in category field, the change or change of other multi-forms can also be made on the basis of the above description
It is dynamic.There is no need to be exhaustive to all of embodiment, and the obvious change thus amplified out or change
Among moving still in the invention scope of the claims.
Claims (5)
1. a kind of health food preparation of strong anti-oxidation anti anoxia, it is characterised in that：Match somebody with somebody according to parts by weight including following raw materials according
System is formed：0.1～10 part of general ginsenoside, 20～1500 parts of the red sage root, 20～1500 parts of grape pip, 10～800 parts of haematococcus, ox
10～200 parts of sulfonic acid, 10～80 parts of gamma aminobutyric acid.
2. a kind of health food preparation of strong anti-oxidation anti anoxia, it is characterised in that：Match somebody with somebody according to parts by weight including following raw materials according
System is formed：5 parts of general ginsenoside, 1000 parts of the red sage root, 860 parts of grape pip, 26 parts of haematococcus, 80 parts of taurine, gamma aminobutyric acid
72 parts.
3. a kind of health food preparation of strong anti-oxidation anti anoxia, it is characterised in that：Match somebody with somebody according to parts by weight including following raw materials according
System is formed：1.8 parts of general ginsenoside, 1200 parts of the red sage root, 60 parts of grape pip, 780 parts of haematococcus, 160 parts of taurine, γ amino fourths
20 parts of acid.
4. a kind of health food preparation of strong anti-oxidation anti anoxia, it is characterised in that：Match somebody with somebody according to parts by weight including following raw materials according
System is formed：0.2 part of general ginsenoside, 600 parts of the red sage root, 1280 parts of grape pip, 505 parts of haematococcus, 50 parts of taurine, γ amino fourths
46 parts of acid.
5. a kind of health food preparation as claimed in claim 1 or 2 or 3 or 4 is preparing a kind of strong anti-oxidation anti anoxia health care
Application in food.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611061763.2A CN106616595A (en) | 2016-11-16 | 2016-11-16 | Health-care food preparation having strong oxidation resistance and oxygen deficient resistance and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611061763.2A CN106616595A (en) | 2016-11-16 | 2016-11-16 | Health-care food preparation having strong oxidation resistance and oxygen deficient resistance and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106616595A true CN106616595A (en) | 2017-05-10 |
Family
ID=58811582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611061763.2A Pending CN106616595A (en) | 2016-11-16 | 2016-11-16 | Health-care food preparation having strong oxidation resistance and oxygen deficient resistance and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106616595A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109123031A (en) * | 2018-09-11 | 2019-01-04 | 万光瑞 | A kind of salubrity anti-cancer composition and preparation method thereof |
| CN112042796A (en) * | 2020-08-03 | 2020-12-08 | 北京体育大学 | Anti-hypoxia energy bar and preparation method and application thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1961905A (en) * | 2005-11-11 | 2007-05-16 | 北京奇源益德药物研究所 | Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| CN101564423A (en) * | 2008-04-25 | 2009-10-28 | 北京因科瑞斯生物制品研究所 | Medicament for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| CN101683387A (en) * | 2008-09-27 | 2010-03-31 | 广州市香雪制药股份有限公司 | Medication and preparation method and application thereof |
| CN102240322A (en) * | 2011-07-01 | 2011-11-16 | 天圣制药集团股份有限公司 | Compound red sage root tablet and preparing process thereof |
| CN102935130A (en) * | 2012-12-08 | 2013-02-20 | 南京正宽医药科技有限公司 | Traditional Chinese medicine composition for improving anoxia endurance as well as preparation method and application thereof |
| CN105497515A (en) * | 2015-12-29 | 2016-04-20 | 吉林省现代中药工程研究中心有限公司 | Jingqi double-ginseng composition with anti-anoxia effect |
| CN105533733A (en) * | 2015-12-03 | 2016-05-04 | 新乡医学院 | Health-care food preparation capable of improving hypoxia resistance |
| CN105663493A (en) * | 2016-03-02 | 2016-06-15 | 新乡医学院 | Traditional Chinese medicine health-care combination with anti-oxidation and anti-hypoxia effects |
-
2016
- 2016-11-16 CN CN201611061763.2A patent/CN106616595A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1961905A (en) * | 2005-11-11 | 2007-05-16 | 北京奇源益德药物研究所 | Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| CN101564423A (en) * | 2008-04-25 | 2009-10-28 | 北京因科瑞斯生物制品研究所 | Medicament for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| CN101683387A (en) * | 2008-09-27 | 2010-03-31 | 广州市香雪制药股份有限公司 | Medication and preparation method and application thereof |
| CN102240322A (en) * | 2011-07-01 | 2011-11-16 | 天圣制药集团股份有限公司 | Compound red sage root tablet and preparing process thereof |
| CN102935130A (en) * | 2012-12-08 | 2013-02-20 | 南京正宽医药科技有限公司 | Traditional Chinese medicine composition for improving anoxia endurance as well as preparation method and application thereof |
| CN105533733A (en) * | 2015-12-03 | 2016-05-04 | 新乡医学院 | Health-care food preparation capable of improving hypoxia resistance |
| CN105497515A (en) * | 2015-12-29 | 2016-04-20 | 吉林省现代中药工程研究中心有限公司 | Jingqi double-ginseng composition with anti-anoxia effect |
| CN105663493A (en) * | 2016-03-02 | 2016-06-15 | 新乡医学院 | Traditional Chinese medicine health-care combination with anti-oxidation and anti-hypoxia effects |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109123031A (en) * | 2018-09-11 | 2019-01-04 | 万光瑞 | A kind of salubrity anti-cancer composition and preparation method thereof |
| CN112042796A (en) * | 2020-08-03 | 2020-12-08 | 北京体育大学 | Anti-hypoxia energy bar and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101574140B (en) | Drink composition with human immunity strengthening and anti-fatigue functions | |
| CN103263608B (en) | Chinese medicinal raw powder for detoxifying and beautifying | |
| CN101438843A (en) | Garden stuff soymilk series beverage | |
| Dwivedi et al. | The concept of aging in Ayurveda | |
| CN107156832A (en) | It is a kind of to improve the health food of memory | |
| CN104474429A (en) | Traditional Chinese medicine preparation with function of reducing hypomnesis | |
| CN107455625A (en) | A kind of nutrient for plants beverage and its preparation technology with antifatigue weight losing function | |
| CN103952278A (en) | Maca mineral spring wine and production method for same | |
| CN105232907A (en) | Beverage capable of invigorating kidney and strengthening Yang and making method thereof | |
| CN101669624B (en) | Chinese medicinal assorted Chinese herbal tea with function of improving woman anemia and preparation method thereof | |
| CN104273596A (en) | Tomato-kiwi fruit-and-vegetable-juice beverage | |
| CN106616595A (en) | Health-care food preparation having strong oxidation resistance and oxygen deficient resistance and application | |
| CN107252095A (en) | composite enzyme and preparation method thereof | |
| JP2009013083A (en) | Orally administerable composition | |
| CN103238889A (en) | Anti-fatigue apple vinegar health beverage and preparation method thereof | |
| CN109077321A (en) | A kind of composition and preparation method thereof with strengthen immunity and antioxidation | |
| CN109170470A (en) | A kind of solid beverage and preparation method thereof for treating diabetes | |
| CN101715984B (en) | Spirulina capsule and manufacturing process thereof | |
| CN102090637A (en) | Collagen-containing compound nutritious powder | |
| CN116076710A (en) | Rose herbal ferment with anti-aging and whitening functions and preparation method and application thereof | |
| CN105533733A (en) | Health-care food preparation capable of improving hypoxia resistance | |
| CN106720822A (en) | A kind of chocolate with invigorating the lung and benefiting vital QI effect | |
| CN102119939A (en) | Angiosperm bee pollen water extract for treating fatty liver and preparation method and application thereof | |
| CN105534789B (en) | A kind of natural flavour mountaineous health-care toothpaste | |
| CN106929363A (en) | A kind of health care vina and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |
|
| RJ01 | Rejection of invention patent application after publication |